BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21914469)

  • 21. [Application of next-generation semiconductor sequencing technologies in genetic diagnosis of inherited cardiomyopathies].
    Zhao Y; Zhang H; Xia XS
    Yi Chuan; 2015 Jul; 37(7):635-44. PubMed ID: 26351163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction into the analysis of high-throughput-sequencing based epigenome data.
    Huss M
    Brief Bioinform; 2010 Sep; 11(5):512-23. PubMed ID: 20457755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next generation sequencing is here now.
    Erickson RP
    Lymphology; 2014 Dec; 47(4):196-7. PubMed ID: 25915980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis for heterogeneous genetic diseases with targeted high-throughput DNA sequencing applied to retinitis pigmentosa.
    Simpson DA; Clark GR; Alexander S; Silvestri G; Willoughby CE
    J Med Genet; 2011 Mar; 48(3):145-51. PubMed ID: 21147909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic cardiomyopathies.
    Wilcox JE; Hershberger RE
    Curr Opin Cardiol; 2018 May; 33(3):354-362. PubMed ID: 29561320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advantages of next-generation sequencing versus the microarray in epigenetic research.
    Hurd PJ; Nelson CJ
    Brief Funct Genomic Proteomic; 2009 May; 8(3):174-83. PubMed ID: 19535508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation sequencing: ready for the clinics?
    Desai AN; Jere A
    Clin Genet; 2012 Jun; 81(6):503-10. PubMed ID: 22375550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects.
    Vrijenhoek T; Kraaijeveld K; Elferink M; de Ligt J; Kranendonk E; Santen G; Nijman IJ; Butler D; Claes G; Costessi A; Dorlijn W; van Eyndhoven W; Halley DJ; van den Hout MC; van Hove S; Johansson LF; Jongbloed JD; Kamps R; Kockx CE; de Koning B; Kriek M; Lekanne Dit Deprez R; Lunstroo H; Mannens M; Mook OR; Nelen M; Ploem C; Rijnen M; Saris JJ; Sinke R; Sistermans E; van Slegtenhorst M; Sleutels F; van der Stoep N; van Tienhoven M; Vermaat M; Vogel M; Waisfisz Q; Marjan Weiss J; van den Wijngaard A; van Workum W; Ijntema H; van der Zwaag B; van IJcken WF; den Dunnen J; Veltman JA; Hennekam R; Cuppen E
    Eur J Hum Genet; 2015 Sep; 23(9):1142-50. PubMed ID: 25626705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic diagnostics for cardiomyopathies].
    Czepluch F; Wollnik B; Hasenfuß G
    Dtsch Med Wochenschr; 2017 May; 142(9):657-664. PubMed ID: 28454199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next generation sequencing for TCR repertoire profiling: platform-specific features and correction algorithms.
    Bolotin DA; Mamedov IZ; Britanova OV; Zvyagin IV; Shagin D; Ustyugova SV; Turchaninova MA; Lukyanov S; Lebedev YB; Chudakov DM
    Eur J Immunol; 2012 Nov; 42(11):3073-83. PubMed ID: 22806588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contribution of next generation sequencing to epilepsy genetics.
    Møller RS; Dahl HA; Helbig I
    Expert Rev Mol Diagn; 2015; 15(12):1531-8. PubMed ID: 26565596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of RNA-Seq libraries from large and microscopic tissues for the Illumina sequencing platform.
    Atamian HS; Kaloshian I
    Methods Mol Biol; 2012; 883():47-57. PubMed ID: 22589123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome sequencing: dual role as a discovery and diagnostic tool.
    Ku CS; Cooper DN; Polychronakos C; Naidoo N; Wu M; Soong R
    Ann Neurol; 2012 Jan; 71(1):5-14. PubMed ID: 22275248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding DNA diagnostic panel testing: is more better?
    Klee EW; Hoppman-Chaney NL; Ferber MJ
    Expert Rev Mol Diagn; 2011 Sep; 11(7):703-9. PubMed ID: 21902532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic diagnosis of neuroacanthocytosis disorders using exome sequencing.
    Walker RH; Schulz VP; Tikhonova IR; Mahajan MC; Mane S; Arroyo Muniz M; Gallagher PG
    Mov Disord; 2012 Apr; 27(4):539-43. PubMed ID: 22038564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next generation sequencing in endocrine practice.
    Forlenza GP; Calhoun A; Beckman KB; Halvorsen T; Hamdoun E; Zierhut H; Sarafoglou K; Polgreen LE; Miller BS; Nathan B; Petryk A
    Mol Genet Metab; 2015; 115(2-3):61-71. PubMed ID: 25958132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.
    Robyns T; Kuiperi C; Breckpot J; Devriendt K; Souche E; Van Cleemput J; Willems R; Nuyens D; Matthijs G; Corveleyn A
    Eur J Hum Genet; 2017 Dec; 25(12):1313-1323. PubMed ID: 29255176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-generation sequencing methods: impact of sequencing accuracy on SNP discovery.
    Chan EY
    Methods Mol Biol; 2009; 578():95-111. PubMed ID: 19768588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massively parallel sequencing platforms using lab on a chip technologies.
    Ahmadian A; Svahn HA
    Lab Chip; 2011 Aug; 11(16):2653-5. PubMed ID: 21503304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.